As part of Life Edit Therapeutics’ Technology Development department, Michael focuses on automation support and development.
Prior to joining Life Edit, he worked in the core technology group at Precision Biosciences in Durham, and has a background in cell culture, automated mRNA synthesis and nuclease screening. Michael received a B.S. in Biochemistry and a B.A. in Mathematics from Queens University of Charlotte.
.svg)
.svg)
To rewrite the future by curing disease, making any edit, anywhere.
To pave the way to faster, safer, gene editing therapeutics that cure disease and improve patient lives.
We’re guided by curiosity, rigor, and integrity. We believe in discovery and unlimited potential. We care about science and the lives of patients.
